EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort

Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Alex Al Khoury, Peter L Lakatos iD

Journal of Crohn's and Colitis · 2023

DOI: 10.1093/ecco-jcc/jjad117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, 2023. Verfasst von Lorant Gonczi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Source of the National Research, Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Few population-based studies have investigated long-term surgery rates for Crohn’s disease [CD]. Our aim was to analyse disease progression and surgery rates in a population-based cohort over different therapeutic eras, based on the time of diagnosis: cohort-A [1977–1995], cohort-B [1996–2008], and cohort-C [2009–2018].

Methods

A total of 946 incident CD patients were analysed (male/female: 496/450; median age at diagnosis: 28 years [y]; interquartile range [IQR]: 22–40]). Patient inclusion lasted between 1977 and 2018. Immunomodulators have become widespread in Hungary since the mid-1990s and biologic therapies since 2008. Patients were followed prospectively, with both in-hospital and outpatient records reviewed regularly.

Results

The probability of disease behaviour progression from inflammatory [B1] to stenosing or penetrating phenotype [B2/B3] significantly decreased (27.1 ± 5.3%/21.5 ± 2.5%/11.3 ± 2.2% in cohorts A/B/C, respectively, after 5 years; 44.3 ± 5.9%/30.6 ± 2.8%/16.1 ± 2.9% after 10 years, respectively; [pLogRank <0.001]). The probability of first resective surgery between cohorts A/B/C were 33.3 ± 3.8%/26.5 ± 2.1%/28.1 ± 2.4%, respectively, after 5 years; 46.1 ± 4.1%/32.6 ± 2.2%/33.0 ± 2.7% after 10 years, respectively; and 59.1 ± 4.0%/41.4 ± 2.6% [cohorts A/B] after 20 years. There was a significant decrease in first resective surgery risk between cohorts A and B [plog rank = 0.002]; however, no further decrease between cohorts B and C [plog rank = 0.665]. The cumulative probability of re-resection in cohorts A/B/C was decreasing over time (17.3 ± 4.1%/12.6 ± 2.6%/4.7 ± 2.0%, respectively, after 5 years [plog rank = 0.001]).

Conclusion

We report a continuous decline in reoperation rates and disease behaviour progression in CD over time, with the lowest values in the biologic era. In contrast, there was no further decrease in the probability of first major resective surgery after the immunosuppressive era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseHumansMaleFemaleAdultHungaryProspective StudiesReoperationImmunosuppressive AgentsDisease ProgressionRetrospective Studies

Stichwörter der Autor:innen

Crohn’s diseasebiologicsimmunomodulatorspopulation-basedresective surgery

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary.
  • Department of Gastroenterology, Hungarian Defence Forces Medical Centre, Budapest, Hungary.
  • Department of Gastroenterology, Grof Eszterhazy Hospital, Papa, Hungary.
  • Gastro Health, LLC-Care Center, Hollywood, FL, USA.
  • Division of Gastroenterology, McGill University Health Center, Montreal, QC, Canada.

ORCID-Profile: Peter L Lakatos

Förderung

  • Source of the National Research, Development and Innovation Fund

Zitieren

APA

Gonczi, L., Lakatos, L., Golovics, P. A., Ilias, A., Pandur, T., David, G., Erdelyi, Z., Szita, I., Al Khoury, A., & Lakatos, P. L. (2023). Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjad117

Vancouver

Gonczi L, Lakatos L, Golovics PA, Ilias A, Pandur T, David G, et al. Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort. Journal of Crohn's and Colitis. 2023. doi:10.1093/ecco-jcc/jjad117

BibTeX
@article{Gonczi2023,
  author = {Gonczi, Lorant and Lakatos, Laszlo and Golovics, Petra A and Ilias, Akos and Pandur, Tunde and David, Gyula and Erdelyi, Zsuzsanna and Szita, Istvan and Al Khoury, Alex and Lakatos, Peter L},
  title = {Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort},
  journal = {Journal of Crohn's and Colitis},
  year = {2023},
  doi = {10.1093/ecco-jcc/jjad117}
}
Kostenlos starten →